Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 19 entries
Sorted by: Best Match Show Resources per page
Letter: Looking after schizophrenics.

British medical journal

Sargant W.
PMID: 4407131
Br Med J. 1974 Jun 08;2(5918):557. doi: 10.1136/bmj.2.5918.557.
Free PMC Article

No abstract available.

Cite
Sargant W. Letter: Looking after schizophrenics. Br Med J. 1974;2(5918):557doi: 10.1136/bmj.2.5918.557.
Sargant, W. (1974). Letter: Looking after schizophrenics. British medical journal, 2(5918), 557. https://doi.org/10.1136/bmj.2.5918.557
Sargant, W. "Letter: Looking after schizophrenics." British medical journal vol. 2,5918 (1974): 557. doi: https://doi.org/10.1136/bmj.2.5918.557
Sargant W. Letter: Looking after schizophrenics. Br Med J. 1974 Jun 08;2(5918):557. doi: 10.1136/bmj.2.5918.557. PMID: 4407131; PMCID: PMC1610949.
Copy Download .nbib Format: NLM
Treatment and causes of schizophrenia. Proceedings of the VA Medical Research Service Symposium. Denver, Co, October 23, 1989.

Schizophrenia research

[No authors listed]
PMID: 2039763
Schizophr Res. 1991 Mar-Apr;4(2):67-243.

No abstract available.

Cite
Treatment and causes of schizophrenia. Proceedings of the VA Medical Research Service Symposium. Denver, Co, October 23, 1989. Schizophr Res. 1991;4(2):67-243
(1991). Treatment and causes of schizophrenia. Proceedings of the VA Medical Research Service Symposium. Denver, Co, October 23, 1989. Schizophrenia research, 4(2), 67-243.
"Treatment and causes of schizophrenia. Proceedings of the VA Medical Research Service Symposium. Denver, Co, October 23, 1989." Schizophrenia research vol. 4,2 (1991): 67-243.
Treatment and causes of schizophrenia. Proceedings of the VA Medical Research Service Symposium. Denver, Co, October 23, 1989. Schizophr Res. 1991 Mar-Apr;4(2):67-243. PMID: 2039763.
Copy Download .nbib Format: NLM
Clinical comment: schizophrenia.

Nursing mirror

Hopkins SJ.
PMID: 6921692
Nurs Mirror. 1982 Jul 28;155(4):24.

No abstract available.

Cite
Hopkins SJ. Clinical comment: schizophrenia. Nurs Mirror. 1982;155(4):24
Hopkins, S. J. (1982). Clinical comment: schizophrenia. Nursing mirror, 155(4), 24.
Hopkins, S J. "Clinical comment: schizophrenia." Nursing mirror vol. 155,4 (1982): 24.
Hopkins SJ. Clinical comment: schizophrenia. Nurs Mirror. 1982 Jul 28;155(4):24. PMID: 6921692.
Copy Download .nbib Format: NLM
Prognosis of schizophrenia before and after pharmacotherapy.

The British journal of psychiatry : the journal of mental science

Freyhan FA.
PMID: 5665964
Br J Psychiatry. 1968 Jun;114(511):781-2. doi: 10.1192/bjp.114.511.781.

No abstract available.

Cite
Freyhan FA. Prognosis of schizophrenia before and after pharmacotherapy. Br J Psychiatry. 1968;114(511):781-2doi: 10.1192/bjp.114.511.781.
Freyhan, F. A. (1968). Prognosis of schizophrenia before and after pharmacotherapy. The British journal of psychiatry : the journal of mental science, 114(511), 781-2. https://doi.org/10.1192/bjp.114.511.781
Freyhan, F A. "Prognosis of schizophrenia before and after pharmacotherapy." The British journal of psychiatry : the journal of mental science vol. 114,511 (1968): 781-2. doi: https://doi.org/10.1192/bjp.114.511.781
Freyhan FA. Prognosis of schizophrenia before and after pharmacotherapy. Br J Psychiatry. 1968 Jun;114(511):781-2. doi: 10.1192/bjp.114.511.781. PMID: 5665964.
Copy Download .nbib Format: NLM
Practical clinical trials for schizophrenia.

Epidemiologia e psichiatria sociale

Stroup S.
PMID: 16255159
Epidemiol Psichiatr Soc. 2005 Jul-Sep;14(3):132-6. doi: 10.1017/s1121189x00006370.

No abstract available.

Cite
Stroup S. Practical clinical trials for schizophrenia. Epidemiol Psichiatr Soc. 2005;14(3):132-6doi: 10.1017/s1121189x00006370.
Stroup, S. (2005). Practical clinical trials for schizophrenia. Epidemiologia e psichiatria sociale, 14(3), 132-6. https://doi.org/10.1017/s1121189x00006370
Stroup, Scott. "Practical clinical trials for schizophrenia." Epidemiologia e psichiatria sociale vol. 14,3 (2005): 132-6. doi: https://doi.org/10.1017/s1121189x00006370
Stroup S. Practical clinical trials for schizophrenia. Epidemiol Psichiatr Soc. 2005 Jul-Sep;14(3):132-6. doi: 10.1017/s1121189x00006370. PMID: 16255159.
Copy Download .nbib Format: NLM
[From symptomatic stability to functional recovery in the pharmacological treatment of schizophrenia and unipolar depression].

Vertex (Buenos Aires, Argentina)

Wikinski S.
PMID: 20038986
Vertex. 2009 Sep-Oct;20(87):351-8.

This work summarizes the efficacy of pharmacotherapy in the chronic course of schizophrenia and unipolar depresion. It is aimed to answer three questions: does it cure these diseases? Does it exert any significant effect on the symptomatic presentation of...

Cite
Wikinski S. De la estabilización sintomática a la recuperación funcional en el tratamiento farmacológico de la Esquizofrenia y la Depresión Unipolar. [From symptomatic stability to functional recovery in the pharmacological treatment of schizophrenia and unipolar depression]. Vertex. 2009;20(87):351-8
Wikinski, S. (2009). De la estabilización sintomática a la recuperación funcional en el tratamiento farmacológico de la Esquizofrenia y la Depresión Unipolar. [From symptomatic stability to functional recovery in the pharmacological treatment of schizophrenia and unipolar depression]. Vertex (Buenos Aires, Argentina), 20(87), 351-8.
Wikinski, Silvia. "De la estabilización sintomática a la recuperación funcional en el tratamiento farmacológico de la Esquizofrenia y la Depresión Unipolar." [From symptomatic stability to functional recovery in the pharmacological treatment of schizophrenia and unipolar depression]. Vertex (Buenos Aires, Argentina) vol. 20,87 (2009): 351-8.
Wikinski S. De la estabilización sintomática a la recuperación funcional en el tratamiento farmacológico de la Esquizofrenia y la Depresión Unipolar. [From symptomatic stability to functional recovery in the pharmacological treatment of schizophrenia and unipolar depression]. Vertex. 2009 Sep-Oct;20(87):351-8. Spanish. PMID: 20038986.
Copy Download .nbib Format: NLM
[Medicamental treatment of schizophrenia].

Revue medicale de Bruxelles

Lotstra F, Lestienne S, De Nayer A.
PMID: 21089395
Rev Med Brux. 2010 Sep;31(4):226-30.

Antipsychotics play a key role in biologic therapy of schizophrenia. Following the first-generation neuroleptics, associated with many extrapyramidal side effects (severe dystonias, parkinsonian syndrome, akatisia and late dyskinesia) altering patients' compliance to the treatment, one can now find a...

Cite
Lotstra F, Lestienne S, De Nayer A. Traitement médicamenteux de la schizophrénie. [Medicamental treatment of schizophrenia]. Rev Med Brux. 2010;31(4):226-30
Lotstra, F., Lestienne, S., & De Nayer, A. (2010). Traitement médicamenteux de la schizophrénie. [Medicamental treatment of schizophrenia]. Revue medicale de Bruxelles, 31(4), 226-30.
Lotstra, F, et al. "Traitement médicamenteux de la schizophrénie." [Medicamental treatment of schizophrenia]. Revue medicale de Bruxelles vol. 31,4 (2010): 226-30.
Lotstra F, Lestienne S, De Nayer A. Traitement médicamenteux de la schizophrénie. [Medicamental treatment of schizophrenia]. Rev Med Brux. 2010 Sep;31(4):226-30. French. PMID: 21089395.
Copy Download .nbib Format: NLM
Efficacy and safety of Ninjin'yoeito (NYT) in treatment-resistant schizophrenia: Open-Label Study.

Asian journal of psychiatry

Miyaoka T, Wake R, Araki T, Inoue K, Horiguchi J.
PMID: 33962269
Asian J Psychiatr. 2021 Jun;60:102662. doi: 10.1016/j.ajp.2021.102662. Epub 2021 Apr 26.

No abstract available.

Cite
Miyaoka T, Wake R, Araki T, et al. Efficacy and safety of Ninjin'yoeito (NYT) in treatment-resistant schizophrenia: Open-Label Study. Asian J Psychiatr. 2021;60:102662doi: 10.1016/j.ajp.2021.102662.
Miyaoka, T., Wake, R., Araki, T., Inoue, K., & Horiguchi, J. (2021). Efficacy and safety of Ninjin'yoeito (NYT) in treatment-resistant schizophrenia: Open-Label Study. Asian journal of psychiatry, 60102662. https://doi.org/10.1016/j.ajp.2021.102662
Miyaoka, Tsuyoshi, et al. "Efficacy and safety of Ninjin'yoeito (NYT) in treatment-resistant schizophrenia: Open-Label Study." Asian journal of psychiatry vol. 60 (2021): 102662. doi: https://doi.org/10.1016/j.ajp.2021.102662
Miyaoka T, Wake R, Araki T, Inoue K, Horiguchi J. Efficacy and safety of Ninjin'yoeito (NYT) in treatment-resistant schizophrenia: Open-Label Study. Asian J Psychiatr. 2021 Jun;60:102662. doi: 10.1016/j.ajp.2021.102662. Epub 2021 Apr 26. PMID: 33962269.
Copy Download .nbib Format: NLM
Cognitive insight is correlated with cognitive impairments and contributes to medication adherence in schizophrenia patients.

Asian journal of psychiatry

Lui SSY, Lam JPY, Lam JWS, Chui WWH, Mui JHC, Siu BWM, Cheng KM, Cheung EFC, Chan RCK.
PMID: 33862475
Asian J Psychiatr. 2021 Jun;60:102644. doi: 10.1016/j.ajp.2021.102644. Epub 2021 Apr 06.

OBJECTIVE: Cognitive insight refers to the ability to distance oneself from and evaluate one's own beliefs and interpretations. Little is known about whether cognitive insight could influence medication adherence in schizophrenia patients. This study examined the role of cognitive...

Cite
Lui SSY, Lam JPY, Lam JWS, et al. Cognitive insight is correlated with cognitive impairments and contributes to medication adherence in schizophrenia patients. Asian J Psychiatr. 2021;60:102644doi: 10.1016/j.ajp.2021.102644.
Lui, S. S. Y., Lam, J. P. Y., Lam, J. W. S., Chui, W. W. H., Mui, J. H. C., Siu, B. W. M., Cheng, K. M., Cheung, E. F. C., & Chan, R. C. K. (2021). Cognitive insight is correlated with cognitive impairments and contributes to medication adherence in schizophrenia patients. Asian journal of psychiatry, 60102644. https://doi.org/10.1016/j.ajp.2021.102644
Lui, Simon S Y, et al. "Cognitive insight is correlated with cognitive impairments and contributes to medication adherence in schizophrenia patients." Asian journal of psychiatry vol. 60 (2021): 102644. doi: https://doi.org/10.1016/j.ajp.2021.102644
Lui SSY, Lam JPY, Lam JWS, Chui WWH, Mui JHC, Siu BWM, Cheng KM, Cheung EFC, Chan RCK. Cognitive insight is correlated with cognitive impairments and contributes to medication adherence in schizophrenia patients. Asian J Psychiatr. 2021 Jun;60:102644. doi: 10.1016/j.ajp.2021.102644. Epub 2021 Apr 06. PMID: 33862475.
Copy Download .nbib Format: NLM
Subjective quality of life and drug treatment for schizophrenia.

The British journal of psychiatry : the journal of mental science

Sengupta S, Kar N.
PMID: 9519114
Br J Psychiatry. 1997 Dec;171:587. doi: 10.1192/bjp.171.6.587b.

No abstract available.

Cite
Sengupta S, Kar N. Subjective quality of life and drug treatment for schizophrenia. Br J Psychiatry. 1997;171:587doi: 10.1192/bjp.171.6.587b.
Sengupta, S., & Kar, N. (1997). Subjective quality of life and drug treatment for schizophrenia. The British journal of psychiatry : the journal of mental science, 171587. https://doi.org/10.1192/bjp.171.6.587b
Sengupta, S, and Kar, N. "Subjective quality of life and drug treatment for schizophrenia." The British journal of psychiatry : the journal of mental science vol. 171 (1997): 587. doi: https://doi.org/10.1192/bjp.171.6.587b
Sengupta S, Kar N. Subjective quality of life and drug treatment for schizophrenia. Br J Psychiatry. 1997 Dec;171:587. doi: 10.1192/bjp.171.6.587b. PMID: 9519114.
Copy Download .nbib Format: NLM
Guest editorial: Special issue on maintenance treatment in schizophrenia.

Schizophrenia research

Emsley R.
PMID: 32220504
Schizophr Res. 2020 Nov;225:1-3. doi: 10.1016/j.schres.2020.03.029. Epub 2020 Mar 24.

No abstract available.

Cite
Emsley R. Guest editorial: Special issue on maintenance treatment in schizophrenia. Schizophr Res. 2020;225:1-3doi: 10.1016/j.schres.2020.03.029.
Emsley, R. (2020). Guest editorial: Special issue on maintenance treatment in schizophrenia. Schizophrenia research, 2251-3. https://doi.org/10.1016/j.schres.2020.03.029
Emsley, Robin. "Guest editorial: Special issue on maintenance treatment in schizophrenia." Schizophrenia research vol. 225 (2020): 1-3. doi: https://doi.org/10.1016/j.schres.2020.03.029
Emsley R. Guest editorial: Special issue on maintenance treatment in schizophrenia. Schizophr Res. 2020 Nov;225:1-3. doi: 10.1016/j.schres.2020.03.029. Epub 2020 Mar 24. PMID: 32220504.
Copy Download .nbib Format: NLM
Is non-pharmacological treatment an option for certain schizophrenia patients?.

Psychiatria Danubina

Matei VP, Mihailescu AI, Davidson M.
PMID: 25377364
Psychiatr Danub. 2014 Dec;26(4):308-13.

BACKGROUND: Schizophrenia treatment has been debated at length and presently pharmacological treatment is being advocated as the most beneficial for patients. However, research has shown contradictory results regarding the suitability of pharmacological treatment for certain groups of schizophrenia patients.METHODS:...

Cite
Matei VP, Mihailescu AI, Davidson M. Is non-pharmacological treatment an option for certain schizophrenia patients?. Psychiatr Danub. 2014;26(4):308-13
Matei, V. P., Mihailescu, A. I., & Davidson, M. (2014). Is non-pharmacological treatment an option for certain schizophrenia patients?. Psychiatria Danubina, 26(4), 308-13.
Matei, Valentin P, et al. "Is non-pharmacological treatment an option for certain schizophrenia patients?." Psychiatria Danubina vol. 26,4 (2014): 308-13.
Matei VP, Mihailescu AI, Davidson M. Is non-pharmacological treatment an option for certain schizophrenia patients?. Psychiatr Danub. 2014 Dec;26(4):308-13. PMID: 25377364.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 19 entries